The Compatibility of Nivestim Under Cytotoxic Chemotherapy in the Treatment of Malignant Diseases

Trial Profile

The Compatibility of Nivestim Under Cytotoxic Chemotherapy in the Treatment of Malignant Diseases

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Apr 2017

At a glance

  • Drugs Filgrastim (Primary) ; Filgrastim (Primary)
  • Indications Febrile neutropenia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms VENICE
  • Sponsors Hospira
  • Most Recent Events

    • 14 Oct 2016 Results published in the Advances in Therapy
    • 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology
    • 14 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top